What is SeqGen?
SeqGen, Inc. operates as a critical independent service provider within the life sciences ecosystem, focusing on the maintenance, repair, and refurbishment of complex laboratory hardware. The company's portfolio encompasses a broad spectrum of essential diagnostic and analytical tools, including LC-MS systems, genetic analyzers, and real-time PCR platforms. By offering flexible service packages, SeqGen addresses the growing demand for cost-effective, high-quality technical support, allowing research institutions and clinical laboratories to extend the operational lifecycle of their capital-intensive equipment. Their market position is defined by a commitment to technical precision and customer-centric service models that bridge the gap between original equipment manufacturer support and budget-constrained laboratory requirements.
How much funding has SeqGen raised?
SeqGen has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in SeqGen
PPP
Public-Private Partnership
What's next for SeqGen?
With this late-stage financing, SeqGen is positioned to accelerate its service footprint and potentially expand its technical capabilities into emerging diagnostic technologies. The strategic allocation of this capital will likely focus on enhancing the company's logistics network and deepening its expertise in high-throughput instrumentation. As laboratories globally face increasing pressure to optimize operational expenditures, SeqGen's model of providing reliable, independent maintenance services is well-aligned with current industry trends. Future growth will likely be driven by scaling their service technician workforce and investing in advanced diagnostic tools to support a wider array of next-generation laboratory equipment, ensuring they remain a preferred partner for research facilities seeking to maximize their hardware investments.
See full SeqGen company page
